Literature DB >> 10391452

Anticonvulsant actions of furosemide in vitro.

K U Gutschmidt1, K Stenkamp, K Buchheim, U Heinemann, H Meierkord.   

Abstract

Anticonvulsant properties of furosemide have been suggested to reduce neuronal synchronization via its inhibitory effect on the Na+/K+/2Cl- co-transport system. We have studied effects of furosemide on spontaneous epileptiform activity and analysed effects of furosemide on amplitudes of stimulus-induced population-spikes, on stimulus-induced K+ changes, on extracellular pH changes at rest and during stimulation, and on changes in the extracellular space-volume. We used three different in vitro models of epilepsy in the combined hippocampal-entorhinal cortex slice preparation. Furosemide reversibly suppressed low Ca2+-induced epileptiform activity in hippocampus proper and blocked or significantly reduced different types of epileptiform discharges in the low Mg2+ model and the 4-aminopyridine model. Amplitudes of evoked field potentials underwent an initial slight increase followed by a significant reduction after prolonged treatment with furosemide. Stimulus-induced increases in extracellular potassium were also significantly reduced. Furosemide caused an alkaline shift at rest. Stimulus-induced pH transients changed from a biphasic alkalotic-acidotic sequence to a monophasic alkalotic shift. Stimulation-induced shrinkage of extracellular space-volume was reduced by furosemide, whereas no effect on baseline extracellular space-volume was seen. We conclude, that furosemide possesses strong anticonvulsive effects in various in vitro models of epilepsy. The anticonvulsive properties of furosemide cannot be explained by its effects on extracellular pH changes but appear in part to be mediated via a reduced excitability with consequent reduction of activity-induced potassium rises. Finally, partial inhibition of activity-induced extracellular space shrinkage may contribute to its anticonvulsant properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391452     DOI: 10.1016/s0306-4522(98)00700-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Differential expression of synaptic and nonsynaptic mechanisms underlying stimulus-induced gamma oscillations in vitro.

Authors:  M A Whittington; H C Doheny; R D Traub; F E LeBeau; E H Buhl
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

2.  Does glutamate released by astrocytes cause focal epilepsy?

Authors:  Raimondo D'Ambrosio
Journal:  Epilepsy Curr       Date:  2006 Sep-Oct       Impact factor: 7.500

Review 3.  Unexpected extra-renal effects of loop diuretics in the preterm neonate.

Authors:  Robert Cotton; Sandra Suarez; Jeff Reese
Journal:  Acta Paediatr       Date:  2012-05-28       Impact factor: 2.299

4.  The K+-Cl cotransporter KCC2 promotes GABAergic excitation in the mature rat hippocampus.

Authors:  Tero Viitanen; Eva Ruusuvuori; Kai Kaila; Juha Voipio
Journal:  J Physiol       Date:  2010-03-08       Impact factor: 5.182

5.  Furosemide depresses the presynaptic fiber volley and modifies frequency-dependent axonal excitability in rat hippocampus.

Authors:  Mogens Andreasen; Steen Nedergaard
Journal:  J Neurophysiol       Date:  2017-01-18       Impact factor: 2.714

6.  Activity-dependent intracellular acidification correlates with the duration of seizure activity.

Authors:  Z Q Xiong; P Saggau; J L Stringer
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 7.  [Refractory status epilepticus: diagnosis, therapy, course, and prognosis].

Authors:  F Bösebeck; G Möddel; K Anneken; M Fischera; S Evers; E B Ringelstein; C Kellinghaus
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

8.  Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivo.

Authors:  Sudhir Sivakumaran; Ross A Cardarelli; Jamie Maguire; Matt R Kelley; Liliya Silayeva; Danielle H Morrow; Jayanta Mukherjee; Yvonne E Moore; Robert J Mather; Mark E Duggan; Nicholas J Brandon; John Dunlop; Stephen Zicha; Stephen J Moss; Tarek Z Deeb
Journal:  J Neurosci       Date:  2015-05-27       Impact factor: 6.167

9.  Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro.

Authors:  Margherita D'Antuono; Rüdiger Köhling; Serena Ricalzone; Jean Gotman; Giuseppe Biagini; Massimo Avoli
Journal:  Epilepsia       Date:  2009-08-19       Impact factor: 5.864

Review 10.  Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.

Authors:  Jamie Maguire; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2012-11-29       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.